Full-Time

Territory Sales Manager

Posted on 8/19/2026

Strive Pharmacy

Strive Pharmacy

501-1,000 employees

Compounding pharmacy platform for personalized medications

Compensation Overview

$80k - $90k/yr

+ 10% commission

Houston, TX, USA

Remote

Remote within the Houston territory, with 70–80% travel throughout the assigned territory.

Bachelor's

Category
Sales & Account Management (1)
Required Skills
Microsoft Office
Sales
Medical Terminology
CRM
HubSpot
Word/Pages/Docs
Salesforce
HIPAA
Excel/Numbers/Sheets
PowerPoint/Keynote/Slides

Get referred to Strive Pharmacy

See people who can refer or advise you

Requirements
  • A bachelor's degree in Business Administration, Marketing, Biological Sciences, Healthcare Administration, or a related field is required.
  • At least 2 years of successful field sales experience is required.
  • A valid driver's license with a clean driving record and willingness to travel extensively, up to 70–80% within the assigned territory, are required.
  • Proficiency with Microsoft Office Suite, including Word, Excel, and PowerPoint, and modern Customer Relationship Management platforms such as HubSpot or Salesforce is required.
  • The candidate must be able to independently manage a field territory, prioritize strategic accounts, and achieve sales objectives in a fast-paced environment.
  • The role requires exceptional interpersonal, negotiation, relationship management, and presentation skills.
  • The candidate must be able to perform frequent automobile travel, visits to medical offices, provider meetings, educational presentations, keyboarding, and computer use, with occasional lifting of marketing materials, clinical display kits, and conference equipment up to 35 pounds.
Responsibilities
  • Develop and execute territory business plans to achieve monthly, quarterly, and annual sales goals within assigned geographic markets.
  • Own clinic growth and retention after handoff, including working with clinics that fall below 10 prescriptions per month before they move into the Customer Success Manager-only bucket.
  • Identify, prospect, and establish new business relationships with healthcare providers, medical specialists, private practices, and clinical organizations.
  • Build and maintain relationships with existing prescribers and clinical teams; conduct regular account reviews to improve satisfaction, support retention, and identify growth opportunities.
  • Deliver in-person educational presentations, clinical lunch-and-learns, and product discussions for prescribers and healthcare teams about custom compounding solutions, dosage forms, and therapeutic options.
  • Monitor regional healthcare trends, provider preferences, and competitive activity to identify growth opportunities and provide market insights to Sales Leadership.
  • Maintain accurate records of field sales activities, provider interactions, pipeline progression, and follow-up activities in Customer Relationship Management software, including HubSpot.
  • Partner with Marketing, Customer Success, and Pharmacy Operations to support regional campaigns, streamline new provider onboarding, and resolve customer needs.
  • Represent Strive Pharmacy at local, regional, and national medical conferences, provider education events, and professional networking opportunities to increase brand awareness and generate new business.
  • Ensure provider interactions, educational presentations, and promotional activities comply with company policies, healthcare compliance requirements, pharmaceutical advertising standards, and Health Insurance Portability and Accountability Act patient privacy regulations.
Desired Qualifications
  • Direct experience selling 503A or 503B compounded pharmaceutical formulations, bioidentical hormone replacement therapies, dermatology products, anti-aging therapies, or integrative medicine solutions.
  • A proven track record of territory growth within pharmaceutical sales, specialty pharmacy, medical device, or healthcare provider services.
  • Strong understanding of medical terminology, provider office workflows, and clinical sales processes.
  • Established relationships with physicians, physician assistants, nurse practitioners, and medical clinics within assigned markets.

Strive Pharmacy creates customized, patient-specific medications prescribed by healthcare providers. It produces these formulations at its compounding facilities and fulfills orders turnkey for partners, including custom packaging and nationwide shipping on a cash-pay basis. The company emphasizes quality with weekly third-party potency testing and holds NABP, PCAB, and LegitScript certifications, supported by vertical integration to assist telehealth partners. Its goal is to advance proactive “well care” by optimizing health outcomes through personalized medicine rather than treating symptoms alone.

Company Size

501-1,000

Company Stage

Seed

Total Funding

$100K

Headquarters

Phoenix, Arizona

Founded

2018

Get referred to Strive Pharmacy

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • LTR Pharma signed Strive as exclusive U.S. pharmacy partner on March 2026.
  • Strive reached 1,000 employees and broke ground on a new Mesa headquarters in 2025.
  • Its antitrust suit against Lilly and Novo Nordisk strengthens its anti-exclusivity positioning in telehealth.

What critics are saying

  • Eli Lilly sued Strive in October 2025 over misleading mass-compounded product advertising.
  • FDA ended Zepbound shortage coverage in 2026, shrinking Strive's GLP-1 compounding runway.
  • If courts restrict 503A personalization claims, Strive's GLP-1-driven growth collapses fast.

What makes Strive Pharmacy unique

  • Michael Walker and Nate Hill built Strive around patient-specific compounding, not retail dispensing.
  • Strive's 50,000-square-foot St. Louis facility supports turnkey telehealth fulfillment and packaging.
  • Weekly third-party potency testing and NABP, PCAB, LegitScript certifications signal tighter quality control.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Health Savings Account/Flexible Spending Account

Parental Leave

401(k) Retirement Plan

401(k) Company Match

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

0%

2 year growth

7%
Stockhead
Jun 11th, 2026
LTR Pharma firms up exclusive US partner for its erectile dysfunction treatment.

LTR Pharma firms up exclusive US partner for its erectile dysfunction treatment. Let's tango! By partnering up, LTR Pharma is making the right moves with its US erectile dysfunction treatment launch. Pic: Getty Images * LTR Pharma inks binding term sheet with Strive Specialties, for exclusive US pharmacy and fulfilment rights for its Roxus ED treatment * The deal marks a key launch-readiness milestone in the company's US commercialisation * LTR and Strive are progressing definitive agreements, ahead of planned US launch Special Report: LTR Pharma has taken another step towards commercialising its Roxus erectile dysfunction treatment in the US, after signing a binding term sheet with Strive Specialties (Strive Pharmacy). LTR Pharma (ASX:LTP) said Strive Pharmacy becomes the exclusive US pharmacy 'fulfilment partner' for Roxus, providing the infrastructure to supply the treatment into the world's largest erectile dysfunction (ED) market. Designed for the US, Roxus is built on the same proprietary intranasal delivery platform as LTR Pharma's foundation product Spontan. Both deliver vardenafil, a PDE5 inhibitor used in oral ED treatments, as a rapid-onset nasal spray. Intranasal delivery offers a much faster onset of action (ten minutes or less). While Spontan progresses through the formal US Food and Drug Administration (FDA) approval pathway, Roxus is designed to provide a faster route to patients through personalised care channels. Roxus will be supplied via the US 503A personalised medicine pathway, which allows a prescriber-directed treatment to be prepared for an individual patient. Under the arrangement with Strive Pharmacy, LTR Pharma will remain the product owner, intellectual property holder and formulation supplier. Strive Pharmacy will manage the pharmacy infrastructure that dispenses Roxus prescriptions. Striving for broader patient access. Strive Pharmacy is a personalised medicine pharmacy, operating across five US states. But Strive also provides a broader national pharmacy, licensed across all 50 states, for compounding, packaging, and shipping prescriptions. The deal runs for an initial two years from commercial launch, with annual renewal unless either party opts out. LTR Pharma said the launch depended on completing technology transfer, pharmacy onboarding and other "readiness requirements". All set for launch lift-off. LTR Pharma executive chairman Lee Rodne said securing an experienced national pharmacy fulfilment partner was an "important launch-readiness milestone" for Roxus. The Strive deal "materially advanced" the company's US commercialisation strategy for Roxus. "Combined with our broader patient acquisition and market access initiatives, the arrangement supports LTR Pharma's planned multi-channel approach to commercialising Roxus in the US." Strive Pharmacy president and co-founder Michael Walker said Roxus was an "innovative addition" to the men's health category. The deal aligned with Strive Pharmacy's focus on personalised medicine and patient-centric care, he said. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions. Investor Guide: Health & Biotech 2026 featuring Tim Boreham

Strive Pharmacy
Apr 28th, 2026
How Strive supports clinics delivering personalized medicine.

How Strive supports clinics delivering personalized medicine. Need to knows. * Scaling personalized medicine services introduces new operational complexity for clinics, including evaluating treatment options, educating staff, and monitoring patient demand. * The Triangle Offense connects clinics with three specialized roles: a Sales Representative, Clinical Liaison, and Customer Success Manager, each supporting partnership development, clinical education, and strategic planning. * Through structured insights and coordinated guidance, clinics gain support that helps navigate operational needs and align workflows with patient care priorities. The challenge of scaling personalized medicine practices. Many clinics exploring personalized medicine quickly discover that expanding services involves more than introducing new therapies. As practices grow, providers must evaluate protocols, educate staff on clinical considerations, and ensure that workflows support individualized patient care. Operational complexity increases as clinics add new offerings and integrate them into existing workflows. Without coordinated support, growth efforts can become fragmented. Clinics may find it difficult to keep workflows aligned, stay current on clinical education, or respond efficiently to patient needs. In many cases, scaling a practice requires guidance that combines clinical education, operational insight, and informed strategy. To help clinics navigate this complexity, Strive developed a collaborative provider support framework known as the Triangle Offense. The model connects clinics with three specialized roles designed to support partnership development, clinical education, and strategic planning. The Triangle Offense model for provider support. The Triangle Offense is designed to support clinics through a coordinated partnership structure. The model connects providers with three roles: * Sales Representative * Clinical Liaison * Customer Success Manager Each role contributes a different perspective to the partnership, creating a structured support system that addresses both clinical and operational aspects of running a modern practice. Rather than relying on a single point of contact, clinics gain access to expertise across relationship development, clinical education, and practice insights. The Creator: Sales Representative. The Creator, also known as the Sales Representative, serves as the primary relationship lead for the clinic. Creators focus on building partnerships with providers and understanding the operational needs of each clinic. Their work includes introducing Strive's product portfolio, discussing pricing considerations, and coordinating provider strategy meetings. By maintaining close relationships with clinics, Creators help identify opportunities where additional services or treatment offerings may align with the clinic's goals. Strategic value: Creators provide visibility into opportunities for expanding services and help connect providers with the appropriate resources within Strive's support structure. The Specialist: Clinical Liaison. The Specialist, also known as the Clinical Liaison, focuses on clinical education and provider guidance. Clinical Liaisons work closely with providers to offer education and answer clinical questions related to compounded medication formulations. Their responsibilities often include: * Offering provider education on product offerings * Answering provider questions about clinical considerations * Helping providers evaluate treatment options for their patient population Because Clinical Liaisons work within the clinical environment, they are able to communicate in terms familiar to providers and support discussions around how services may fit within the clinic's broader treatment approach. Strategic value: Clinical Liaisons help ensure providers have access to the education and guidance needed when evaluating new treatment offerings. The Strategist: Customer Success Manager. The Strategist, also known as the Customer Success Manager (CSM), focuses on long-term partnership support and clinic insights. Customer Success Managers work with multiple clinics and can help identify operational efficiencies and address common workflow questions. Examples of insights often reviewed include: * Order coordination and fulfillment support * Workflow and communication support * Operational questions and issue resolution This support helps clinics stay organized and ensures providers can focus on patient care. CSMs also help coordinate ongoing communication between the clinic and Strive's team. Strategic value: Customer Success Managers provide visibility into practice patterns that can inform future planning and service development. How the Triangle Offense supports practice growth. When these three roles work together, clinics gain access to a structured approach for evaluating growth opportunities. This support framework can help providers: * Navigate operational workflows more efficiently * Access clinical education and formulary information * Coordinate communication with Strive's support team * Address logistical and operational questions as they arise Rather than navigating these decisions independently, providers gain access to coordinated insight that supports thoughtful expansion. The 3-Across Play: strategy meeting. The Triangle Offense framework comes together through structured provider strategy meetings known as the 3-Across Play. These meetings bring together all three roles to discuss clinic insights and future opportunities. The discussion typically follows a structured sequence. Customer Success Manager. The CSM reviews any open operational items, order updates, or workflow questions. Sales Representative. The Sales Representative addresses any logistics, product questions, or coordination needs. Clinical Liaison. The Clinical Liaison provides clinical education and answers provider questions related to treatment options and prescribing considerations. This structured discussion helps create a focused conversation around the clinic's current progress and potential future direction. Moving forward together. Clinics evolve over time. As practices grow, providers frequently reassess which services align with their patients and long-term vision. New treatment options emerge, patient demand shifts, and operational priorities change. Having access to coordinated support can help providers navigate these transitions with greater clarity. The Triangle Offense framework is designed to provide guidance across clinical education, operational insight, and partnership development so clinics can evaluate opportunities and plan future growth with confidence. These conversations are designed to help providers address operational needs and access the clinical and logistical support they need. Reach out to your Strive support team: Email: [email protected] Frequently asked questions about the Triangle Offense model. What is the Triangle Offense model, and how does it support clinics? The Triangle Offense is a provider support framework that connects clinics with three roles: a Sales Representative, Clinical Liaison, and Customer Success Manager. Each role contributes expertise that supports partnership development, clinical education, and strategic planning. How does Strive support clinics delivering personalized medicine? The model brings together relationship development, provider education, and operational support to help clinics navigate day-to-day needs and keep workflows running smoothly. What does a Clinical Liaison do for healthcare providers? Clinical Liaisons provide education and guidance related to product offerings and prescribing considerations. They help providers evaluate treatment options within the context of their clinic's services. How does a Customer Success Manager support clinics? Customer Success Managers help coordinate communication, address operational questions, and ensure clinics have the logistical support they need. Why do clinics need coordinated support when expanding services? Expanding services often requires insight across multiple areas of a practice. Coordinated support can help providers evaluate opportunities and align decisions with long-term clinic goals. [Disclaimer:] [This information is for educational and informational purposes only and is not a treatment recommendation. The information provided relates to patient-specific compounding. Compounded medications are specially prepared for individual patient needs and, as such, have not been reviewed or approved by the U.S. Food and Drug Administration (FDA). The above statements have not been evaluated by the FDA. Prescribers should use their independent clinical judgment when determining appropriateness for individual patients.]

BioSpace
Mar 12th, 2026
Lilly Flags 'Concerning' Impurities in Compounded Tirzepatide

Lilly flags 'concerning' impurities in compounded tirzepatide. March 12, 2026 | Combining tirzepatide with vitamin B12, a common additive in compounded versions of the drug, yields an impurity that could alter the drug's toxicity profile and pose safety risks to patients, the company said in an open letter. Eli Lilly has warned the public about potential safety risks of taking compounded versions of its blockbuster weight-loss and diabetes drug tirzepatide. In particular, the pharma found that many of these remixed formulations combine tirzepatide with vitamin B12, which can react with the active ingredient and yield an impurity, Lilly said in an open letter on Thursday. The impurity is "concerning because nothing is known about its short- or long-term effects in humans," the company added. There is also very little information about how the impurity might alter the way tirzepatide interacts with its target receptors, and whether it might affect the drug's toxicity and immunogenicity. This chemical byproduct could also potentially change how tirzepatide is absorbed into, distributed throughout and cleared from the body, according to Lilly. The impurity "highlights the risks to patients of haphazardly mixing untested additives with complex molecules like tirzepatide without rigorous testing, clinical trials and FDA approval," Lilly said. Lilly has long fought compounding, the practice of making custom formulations of drugs to meet the individual needs of patients or to help supplement supply in the case of a shortage. In October 2024, the FDA declared the tirzepatide shortage over, removing the rationale for allowing its routine compounding. Months later, in April 2025, Lilly launched a strong legal offensive against compounders, suing four telehealth providers for promoting and selling knockoff tirzepatide. In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, formally barring compounders from producing their knockoff versions of the drug. April 23, 2025 In January, Arizona-based provider Strive Compounding Pharmacy hit back with its own lawsuit alleging that Lilly and fellow obesity leader Novo Nordisk are engaged in a "coordinated effort to suppress competition." Efforts of the two companies to stifle compounders, Strive's complaint continued, is "cutting off an essential channel between patients with prescriptions for personalized medicines and the pharmacies that could fill those prescriptions." Lilly countered this argument in its Thursday letter. "In reality, these products are not 'personalized' at all," the company wrote, adding that "untested additivies" are used "under the guise of 'personalization' but that their use by compounders is only seeking to "circumvent the law." Their altered formulations create "a range of new and untested combination drugs," according to the letter. "These so-called 'personalized' compounded tirzepatide products show they may pose even greater risks to patients than previously known," the pharma added. Lilly has good reason to protect its tirzepatide franchise. In 2025, the drug brought in $36.51 billion across its two brands: Mounjaro for type 2 diabetes and Zepbound for chronic weight management. This sum puts Lilly's weight loss portfolio cleanly ahead of Merck's mega blockbuster Keytruda, a cornerstone cancer therapy, which made $31.7 billion last year.

Strive Pharmacy
Dec 16th, 2025
A Milestone Week at Strive: 1,000 Employees, a New Headquarters, and What Comes Next

A milestone week at Strive: 1,000 employees, a new Headquarters, and what comes next. By nate hill, co-founder & CEO, Strive Compounding Pharmacy. Strive Pharmacy hit two major milestones last week at Strive Compounding Pharmacy! Strive Pharmacy officially surpassed 1,000 employees, and Strive Pharmacy broke ground on its new Headquarters in Mesa, AZ. This new building is more than concrete and steel. It reflects the strength of the foundation its team has built and the direction Strive Pharmacy is heading as a company. It will be instrumental in expanding its capabilities, reaching more patients with personalized medicine, and supporting the culture that has become a defining part of who Strive Pharmacy is. Strive Pharmacy ended the week with its Strive Arizona Christmas party. It was a great moment to step back and recognize what this team has accomplished in 2025. The growth, the challenges Strive Pharmacy has navigated, and the commitment its employees bring every day continue to inspire me. Seeing everyone out of scrubs and celebrating together was a reminder of what makes Strive special. A milestone week for its organization and a powerful sign of the momentum ahead. The future of Strive is bright and Strive Pharmacy is just getting started.

PR Newswire
Oct 30th, 2024
Strive Compounding Pharmacy Acquires 50,000 sq. ft. Facility in St. Louis for Turnkey Telehealth Compounding and Fulfillment

Strive Compounding Pharmacy acquires 50,000 sq. ft. Facility in St. Louis for turnkey telehealth compounding and fulfillment.